Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the...
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the US...
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the...
4SC AG (FWB:VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the US Food and Drug...
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced topline results...
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data...
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, has presented novel data on the mechanism of...
4SC AG (Frankfurt, Prime Standard: VSC) and Yakult Honsha Co.; Ltd. (Tokyo: 2267) today announced the grant of an exclusive license by 4SC to Yakult Honsha for the development...
4SC (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced that the first patient has been treated in the Phase I TOPAS study with 4SC-202...
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, today announced its financial results in...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.16 | -2.71186440678 | 5.9 | 6.18 | 5.64 | 751 | 5.69456869 | DE |
| 4 | -0.22 | -3.69127516779 | 5.96 | 6.4 | 4.8099999 | 2299 | 5.69894493 | DE |
| 12 | 0.08 | 1.41342756184 | 5.66 | 6.4 | 3.82 | 2275 | 5.05300442 | DE |
| 26 | 1.24 | 27.5555555556 | 4.5 | 9.5 | 3.82 | 2440 | 5.65036767 | DE |
| 52 | -4.2099999 | -42.3115572092 | 9.9499999 | 10 | 3.82 | 2163 | 6.59796627 | DE |
| 156 | 2.775 | 93.5919055649 | 2.965 | 11.2 | 1.17 | 2537 | 5.19542453 | DE |
| 260 | 3.28 | 133.333333333 | 2.46 | 11.2 | 1.05 | 6241 | 2.60125564 | DE |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
